Nosocomial methicillin resistant staphylococcus aureus pneumonia - Epidemiology and trends based on data of a network of 586 german icus (2005-2009)

European Journal of Medical Research

Volumn 15, Issue 12, 2010, Pages 514-524

  Meyer, Elisabeth ^a,b   Schwab, Frank ^a,b   Gastmeier, Petra ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b National Reference Centre for Surveillance of Nosocomial Infections   (United States)

Author keywords

Age; Change over time; Methicillin resistant staphylococcus aureus; Mortality; Nosocomial; Pneumonia; Risk factor

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; DALFOPRISTIN PLUS QUINUPRISTIN; FOSFOMYCIN; FUSIDIC ACID; GLYCOPEPTIDE; LINEZOLID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

AGE; ARTICLE; ARTIFICIAL VENTILATION; HAND WASHING; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; PATHOPHYSIOLOGY; PATIENT CARE; SCREENING TEST; SKIN DECONTAMINATION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 78650534717     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-15-12-514     Document Type: Article

References (71)

1. Ruden H, Gastmeier P, Daschner FD, Schumacher M. Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP). Infection 1997;25(4):199-202.
2. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, Quade D, Shachtman RH, Schaberg DR, Shah BV, Schatz GD. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. AmJ Med1981; 70(4): 947-59.
3. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med 2003;31(10):2544-51.
4. Rello J. Impact of nosocomial infections on outcome: myths and evidence. Infect Control Hosp Epidemiol 1999;20(6):392-4.
5. Heyland DK, Cook DJ, Griffith L, Keenan SP, BrunBuisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Resp Critl Care Med 2004 1999;159(4 Pt 1):1249-56.
6. Gastmeier P, Geffers C. [Nosocomial infections in Germany. What are the numbers, based on the estimates for 2006?]. Deutsche medizinische Wochenschrift 2008; 133(21):1111-5.
7. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, Leblebicioglu H, Abu Khader I, Miranda Novales MG, Berba R, Ramirez Wong FM, Barkat A, Pino OR, Dueñas L, Mitrev Z, Bijie H, Gurskis V, Kanj SS, Mapp T, Hidalgo RF, Ben Jaballah N, Raka L, Gikas A, Ahmed A, Thu le TA, Guzman Siritt ME; INICC Members. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control; 38(2):95-104 e2.
8. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, Dudeck MA, Pollock DA, Horan TC.National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37(10):783-805.
9. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK; National Healthcare Safety Network Team NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11): 996-1011.
10. Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG Jr, Fisman DN, Johnson JA. Summer Peaks in the Incidences of Gram-Negative Bacterial Infection Among Hospitalized Patients. Infect Control Hosp Epidemiol 2008;29(12): 1124-31.
11. Anderson DJ, Richet H, Chen LF, Spelman DW, Hung YJ, Huang AT, Sexton DJ, Raoult D. Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents. J Inf Dis 2008;197(5):752-6.
12. Kaier K, Frank U, Conrad A, Meyer E. Seasonal and Ascending Trends in the Incidence of Carriage of Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella Species in 2 German Hospitals. Infect Control Hosp Epidemiol. 2010;31(11):1154-9.
13. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298(15):1763-71.
14. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature reviews 2009;7(9):629-41.
15. Chini V, Petinaki E, Foka A, Paratiras S, Dimitracopoulos G, Spiliopoulou I. Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect 2006;12(1):29-34.
16. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008;198(3):336-43.
17. Sopena N, Sabria M. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 2005; 127(1):213-9.
18. Defres S, Marwick C, Nathwani D. MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia. Eur Respir J 2009;34(6):1470-6.
19. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010;38(4 Suppl):e91-7.
20. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002;49(6):999-1005.
21. DeRyke CA, Lodise TP, Jr., Rybak MJ, McKinnon PS. Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 2005;128(3):1414-22.
22. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Australia 2001;175(5): 264-7.
23. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillinsusceptible Staphylococcus aureus bacteremia: a metaanalysis. Clin Infect Dis 2003;36(1):53-9.
24. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36(5):592-8.
25. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, Rodriguez-Roisin R. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. AmJ Resp Crid Care Med 1994;150(6 Pt 1):1545-9.
26. Ibelings MM, Bruining HA. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Europ J Surg 1998; 164(6):411-8.
27. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999;29(5):1171-7.
28. Combes A, Luyt CE, Fagon JY, Wollf M, Trouillet JL, Gibert C, Chastre J; PNEUMA Trial Group. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Resp Critl Care Med 2004;170(7):786-92.
29. Athanassa Z, Siempos, II, Falagas ME. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J 2008;31(3): 625-32.
30. Vidaur L, Planas K, Sierra R, Dimopoulos G, Ramirez A, Lisboa T, Rello J. Ventilator-associated pneumonia: impact of organisms on clinical resolution and medical resources utilization. Chest 2008;133(3):625-32.
31. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Critical Care 2006;10(3): R97.
32. Shorr AF, Combes A, Kollef MH, Chastre J. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 2006;34(3):700-6.
33. Shorr AF, Haque N, Taneja C, Zervos M, Lamerato L, Kothari S, Zilber S, Donabedian S, Perri MB, Spalding J, Oster G. Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol;48(9):3258-62.
34. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Health care-associated invasive MRSA infections, 2005-2008. JAMA; 304(6):641-8.
35. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27(6): 520-32.
36. Moalla M, Baratin D, Giard M, Vanhems P. Incidence of methicillin-resistant Staphylococcus aureus nosocomial infections in intensive care units in Lyon University hospitals, France, 2003-2006. Infect Control Hosp Epidemiol 2008;29(5):454-6.
37. Tacconelli E, De Angelis G. Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management. Current Opinion Pulm Med 2009;15(3):218-22.
38. Welte T, Pletz MW. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Int J Antimicrobial Agents 2010;36(5):391-400.
39. Walkey AJ, O'Donnell MR, Wiener RS. Linezolid versus Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia: A Meta-Analysis of Randomized Controlled Trials. Chest 2010 (epub Sep 23).
40. Jung YJ, Koh Y, Hong SB, Chung JW, Ho Choi S, Kim NJ, Kim MN, Choi IS, Han SY, Kim WD, Yun SC, Lim CM. Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. Crit Care Med 2010; 38(1): 175-80.
41. Falagas ME, Roussos N, Gkegkes ID, Rafailidis PI, Karageorgopoulos DE. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opinion Investig Drugs 2009;18(7):921-44.
42. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilatorassociated pneumonia. Jt Comm J Qual Patient Saf 2005;31(5):243-8.
43. Bird D, Zambuto A, O'Donnell C, Silva J, Kom C, Burke R, Burke P, Agarwal S. Adherence to ventilator-associated pneumonia bundle and incidence of ventilator-associated pneumonia in the surgical intensive care unit. Arch Surg;145(5):465-70.
44. Rello J, Lode H, Cornaglia G, Masterton R. A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 2010;36(5):773-80.
45. Emilson CG. Susceptibility of various microorganisms to Chlorhexidine. Scand J Dental Res 1977;85(4):255-65.
46. Koeman M, van der Ven AJ, Hak E, Joore HC, Kaasjager K, de Smet AG, Ramsay G, Dormans TP, Aarts LP, de Bel EE, Hustinx WN, van der Tweel I, Hoepelman AM, Bon ten MJ. Oral decontamination with Chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Resp Crit Care Medicine 2006; 173(12):1348-55.
47. Scannapieco FA, Yu J, Raghavendran K, Vacanti A, Owens SI, Wood K, Mylotte JM. A randomized trial of Chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care 2009;13(4):R117.
48. Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and Chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007;28(10):1155-61.
49. Evans HL, Dellit TH, Chan J, Nathens AB, Maier RV, Cuschieri J. Effect of Chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg;145(3):240-6.
50. Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES. The effect of daily bathing with Chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009;37(6): 1858-65.
51. Krishna BV, Gibb AP. Use of octenidine dihydrochloride in meticillin-resistant Staphylococcus aureus decolonisation regimens: a literature review. J Hosp Infect 2010; 74(3):199-203.
52. Rammelkamp CH, Jr., Mortimer EA, Jr., Wolinsky E. Transmission of Streptococcal and Staphylococcal Infections. Annals Int Med 1964;60:753-8.
53. Grundmann H, Hori S, Winter B, Tami A, Austin DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 2002;185(4):481-8.
54. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV.. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356(9238):1307-12.
55. Sroka S, Gastmeier P, Meyer E. Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature. J Hosp Infect 2010; 74(3):204-11.
56. Lucet JC, Regnier B. Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus? Clin Infect Dis 2010;51(5):585-90.
57. Robicsek A, Suseno M, Beaumont JL, Thomson RB, Jr., Peterson LR. Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol 2008;46(2): 588-92.
58. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, Renzi G, Vernaz N, Sax H, Pittet D. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299(10):1149-57.
59. Tacconelli E, De Angelis G, de Waure C, Cataldo MA, La Torre G, Cauda R. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009; 9(9):546-54.
60. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008; 8(5): 289-301.
61. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. AmJ Infect Control 2007;35(10 Suppl 2): S165-S93.
62. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004; 329(7465): 533.
63. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Cookson B, Shaw S, Kibbler C, Singer M, Bellingan G, Wilson AP. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005;365(9456):295- 304.
64. Evans HL, Shaffer MM, Hughes MG, Smith RL, Chong TW, Raymond DP, Pelletier SJ, Pruett TL, Sawyer RG. Contact isolation in surgical patients: a barrier to care? Surgery 2003;134(2):180-8.
65. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003; 290(14):1899-905.
66. Barwolff S, Sohr D, Geffers C, Brandt C, Vonberg RP, Halle H, Rüden H, Gastmeier P. Reduction of surgical site infections after Caesarean delivery using surveillance. J Hosp Infect 2006;64(2):156-61.
67. Larue A, Loos-Ayav C, Jay N, Commun N, Rabaud C, Bollaert PE. [Impact on morbidity and costs of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in intensive care patients]. Presse Med 2009;38(1): 25-33.
68. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Ruden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection 2005;33(2):50-5.
69. Zahar JR, Clec'h C, Tafflet M, Garrouste-Orgeas M, Jamali S, Mourvillier B, De Lassence A, Descorps-Declere A, Adrie C, Costa de Beauregard ALA, Azoulay E, Schwebel C, Timsit JF; Outcomerea Study Group. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? CUn Infect Dis 2005;41(9):1224-31.
70. Pujol M, Corbella X, Pena C, Pallares R, Dorca J, Verdaguer R, Diaz-Prieto A, Ariza J, Gudiol F. Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 1998;17(9):622-8.
71. Neely AN, Maley MP. Survival of Enterococci and Staphylococci on Hospital Fabrics and Plastic. J Clin Microbiol 2000; 38 (2): 724-726.